Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) rose 3.2% during trading on Monday . The company traded as high as C$0.64 and last traded at C$0.64. Approximately 2,020 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 22,788 shares. The stock had previously closed at C$0.62.
Crescita Therapeutics Price Performance
The company has a current ratio of 3.37, a quick ratio of 2.29 and a debt-to-equity ratio of 6.02. The business’s fifty day moving average is C$0.59 and its 200 day moving average is C$0.55. The firm has a market capitalization of C$12.40 million, a P/E ratio of -4.27 and a beta of 1.69.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Featured Stories
- Five stocks we like better than Crescita Therapeutics
- Golden Cross Stocks: Pattern, Examples and Charts
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- How to Read Stock Charts for Beginners
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
